Back to search

Article

A Phase IV, open-label, single-arm, multicentric clinical trial for evaluation of Human Papillomavirus 9vHPV vaccine immunogenicity in Men Who Have Sex with Men living with HIV: GeSIDA Study 10017

2025-05-09

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Men who have sex with men (MSM) with HIV are at increased risk for anal cancer, largely attributable to persistent HPV infection. However, data on the nonavalent HPV vaccine (9vHPV) in MSM with HIV older than 26 remain sparse. <h4>Methods</h4> This phase IV trial evaluated the immunogenicity, safety, and impact of age and CD4/CD8 ratio on 9vHPV responses in MSM with HIV up to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5a42e098-9d1d-50c4-8a50-bf0033466e06
DOI
10.1101/2025.05.08.25327237
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Phase IV, open-label, single-arm, multicentric clinical trial for evaluation of Human Papillomavirus 9vHPV vaccine immunogenicity in Men Who Have Sex with Men living with HIV: GeSIDA Study 10017DOI 10.1101/2025.05.08.25327237
Select a neighboring publication to make it the new centre.